Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Pietschmann

Showing results (181-190 of 210) with videos related to

Pageof 21
Sort By:
Nature|July 8, 2021
A condensate-hardening drug blocks RSV replication in vivoJennifer Risso-Ballester, Marie Galloux, Jingjing Cao, et al.
Gastroenterology|March 26, 2010
Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infectionKerstin A Stegmann, Niklas K Björkström, Heike Veber, et al.
Gut|August 27, 2015
Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver miceKoen Vercauteren, Richard J P Brown, Ahmed Atef Mesalam, et al.
Antimicrobial Agents and Chemotherapy|November 8, 2022
Respiratory Syncytial Virus Two-Step Infection Screen Reveals Inhibitors of Early and Late Life Cycle StagesSvenja M Sake, Christina Kosch, Sebastian Blockus, et al.
Antiviral Research|March 22, 2020
Labyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entrySebastian Blockus, Svenja M Sake, Martin Wetzke, et al.
Gastroenterology|April 17, 2012
Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodiesIsabel Fofana, Samira Fafi-Kremer, Patric Carolla, et al.
Cancer Cell|September 28, 2025
A Lymphotoxin-Driven Pathway to Hepatocellular CarcinomaJohannes Haybaeck, Nicolas Zeller, Monika Julia Wolf, et al.
Cancer Cell|October 6, 2009
A lymphotoxin-driven pathway to hepatocellular carcinomaJohannes Haybaeck, Nicolas Zeller, Monika Julia Wolf, et al.
Antimicrobial Agents and Chemotherapy|February 6, 2024
Repurposing screen identifies novel candidates for broad-spectrum coronavirus antivirals and druggable host targetsSibylle Haid, Alina Matthaei, Melina Winkler, et al.
Journal of Virology|November 1, 2013
Analysis of serine codon conservation reveals diverse phenotypic constraints on hepatitis C virus glycoprotein evolutionRichard J P Brown, George Koutsoudakis, Richard A Urbanowicz, et al.
Pageof 21

Showing results (181-190 of 210) with videos related to

Sort By:
Pageof 21
Nature|July 8, 2021
A condensate-hardening drug blocks RSV replication in vivoJennifer Risso-Ballester, Marie Galloux, Jingjing Cao, et al.
Gastroenterology|March 26, 2010
Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infectionKerstin A Stegmann, Niklas K Björkström, Heike Veber, et al.
Gut|August 27, 2015
Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver miceKoen Vercauteren, Richard J P Brown, Ahmed Atef Mesalam, et al.
Antimicrobial Agents and Chemotherapy|November 8, 2022
Respiratory Syncytial Virus Two-Step Infection Screen Reveals Inhibitors of Early and Late Life Cycle StagesSvenja M Sake, Christina Kosch, Sebastian Blockus, et al.
Antiviral Research|March 22, 2020
Labyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entrySebastian Blockus, Svenja M Sake, Martin Wetzke, et al.
Gastroenterology|April 17, 2012
Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodiesIsabel Fofana, Samira Fafi-Kremer, Patric Carolla, et al.
Cancer Cell|September 28, 2025
A Lymphotoxin-Driven Pathway to Hepatocellular CarcinomaJohannes Haybaeck, Nicolas Zeller, Monika Julia Wolf, et al.
Cancer Cell|October 6, 2009
A lymphotoxin-driven pathway to hepatocellular carcinomaJohannes Haybaeck, Nicolas Zeller, Monika Julia Wolf, et al.
Antimicrobial Agents and Chemotherapy|February 6, 2024
Repurposing screen identifies novel candidates for broad-spectrum coronavirus antivirals and druggable host targetsSibylle Haid, Alina Matthaei, Melina Winkler, et al.
Journal of Virology|November 1, 2013
Analysis of serine codon conservation reveals diverse phenotypic constraints on hepatitis C virus glycoprotein evolutionRichard J P Brown, George Koutsoudakis, Richard A Urbanowicz, et al.
Pageof 21